FindTrial
Sign In

Studying the cause of increased red blood cell count in healthy blood donors

Evaluation of blood donors with high hemoglobin

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/05/019460
Enrollment
250
Registered
2019-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

MAHE Directorate of research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Apparently healthy blood donors who are deferred from blood donation for high hemoglobin (Hb >18g/dl) are included for the study

Exclusion criteria

Exclusion criteria: Blood donors with already established cause for high hemoglobin are excluded from the study

Design outcomes

Primary

MeasureTime frame
To identify the underlying the risk of polycythemia vera among blood donors with high hemoglobinTimepoint: April 2020—

Secondary

MeasureTime frame
Further evaluation for risk of thrombosis if requiredTimepoint: May 2020—

Countries

India

Contacts

Public ContactDhivya Kandasamy

Kasturba Medical College

docdhivya99@gmail.com09731532299

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026